Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Return on Equity: 2017-2021

Historic Return on Equity for ENDRA Life Sciences (NDRA) over the last 5 years, with Sep 2021 value amounting to -0.74%.

  • ENDRA Life Sciences' Return on Equity rose 589.00% to -0.74% in Q3 2021 from the same period last year, while for Sep 2021 it was -0.74%, marking a year-over-year increase of 589.00%. This contributed to the annual value of -1.97% for FY2020, which is 45.00% up from last year.
  • According to the latest figures from Q3 2021, ENDRA Life Sciences' Return on Equity is -0.74%, which was down 10.31% from -0.67% recorded in Q2 2021.
  • ENDRA Life Sciences' 5-year Return on Equity high stood at 2.76% for Q1 2017, and its period low was -13.11% during Q3 2018.
  • For the 3-year period, ENDRA Life Sciences' Return on Equity averaged around -3.62%, with its median value being -3.63% (2019).
  • In the last 5 years, ENDRA Life Sciences' Return on Equity slumped by 1,261bps in 2018 and then skyrocketed by 759bps in 2021.
  • Over the past 5 years, ENDRA Life Sciences' Return on Equity (Quarterly) stood at -0.86% in 2017, then slumped by 252bps to -3.38% in 2018, then tumbled by 93bps to -4.32% in 2019, then skyrocketed by 209bps to -2.23% in 2020, then spiked by 589bps to -0.74% in 2021.
  • Its last three reported values are -0.74% in Q3 2021, -0.67% for Q2 2021, and -0.85% during Q1 2021.